A5051425820- Bariatric Surgery and Outcomes
- Esophageal and GI Pathology
- Gastric Cancer Management and Outcomes
- Body Contouring and Surgery
- Diet and metabolism studies
- Gallbladder and Bile Duct Disorders
- Gastrointestinal disorders and treatments
- Gastroesophageal reflux and treatments
- Gastrointestinal Tumor Research and Treatment
- Pancreatic and Hepatic Oncology Research
- Pancreatitis Pathology and Treatment
- Biliary and Gastrointestinal Fistulas
- Minimally Invasive Surgical Techniques
- Liver Disease Diagnosis and Treatment
- Metastasis and carcinoma case studies
- Obesity and Health Practices
- Esophageal Cancer Research and Treatment
- Colorectal Cancer Screening and Detection
- Gastrointestinal Bleeding Diagnosis and Treatment
- Dysphagia Assessment and Management
- Liver Disease and Transplantation
- Surgical Simulation and Training
- Colorectal Cancer Surgical Treatments
- Diabetes Treatment and Management
- Pediatric Hepatobiliary Diseases and Treatments
Harvard University
2016-2025
Brigham and Women's Hospital
2016-2025
Indiana University Bloomington
2024
Boston University
2010-2024
Wright-Patterson Air Force Base
2023-2024
United States Air Force
2022-2024
DecImmune Therapeutics (United States)
2023
Brown University
2023
St James's University Hospital
2022
Weber State University
2022
Objectives: The AspireAssist System (AspireAssist) is an endoscopic weight loss device that comprised of endoscopically placed percutaneous gastrostomy tube and external to facilitate drainage about 30% the calories consumed in a meal, conjunction with lifestyle (diet exercise) counseling. Methods: In this 52-week clinical trial, 207 participants body-mass index (BMI) 35.0–55.0 kg/m2 were randomly assigned 2:1 ratio treatment plus Lifestyle Counseling (n=137; mean BMI was 42.2±5.1 kg/m2) or...
OBJECTIVE To assess procedural safety and glycemic indices at 6 months in a first-in-human study of duodenal mucosal resurfacing (DMR), novel, minimally invasive, upper endoscopic procedure involving hydrothermal ablation the mucosa, patients with type 2 diabetes HbA1c ≥7.5% (58 mmol/mol) on one or more oral antidiabetic agents. RESEARCH DESIGN AND METHODS Using novel balloon catheters, DMR was conducted varying lengths duodenum anesthetized single medical center. RESULTS A total 39...
Importance Obesity is a disease with large socioeconomic burden. Endoscopic sleeve gastroplasty (ESG) minimally invasive endoscopic bariatric procedure wide global adoption. More recently, new weight-loss medications, such as glucagon-like peptide-1 receptor agonists (eg, semaglutide), have attracted increased attention due to their efficacy. However, cost-effectiveness over an extended period compared ESG critical gap that needs be better explored for informed health care decision-making....
Increased use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) has raised safety concerns during endoscopy due to their mechanism delaying gastric emptying. This study aims evaluate the impact GLP-1RAs on technical success and esophagogastroduodenoscopy (EGD). was a retrospective bariatric patients who underwent EGD between January 2022 December 2023. Only were included categorized into those held prior (GLP-HELD group) did not (GLP-CONTINUED group). The primary outcome success,...
Objective Evaluate safety and efficacy of the pose™ procedure for obesity treatment. Methods Subjects with Class I to II were randomized (2:1) receive active or sham procedure, after each investigator performed unblinded lead‐in cases. All subjects provided low‐intensity lifestyle therapy. Efficacy end points mean difference in percent total body weight loss (%TBWL) at 12 months between groups, responder rate achieving ≥5% TBWL. The primary point was incidence reported adverse events....